Javier Díaz-Ferrer, Carolina J Delgado-Flores, Edgar Fermin Yan-Quiroz, Carol Gonzales-Gonzales, Carlos Arroyo-Basto, Tayana Bedregal-Mendoza, Cecilia Yerén-Paredes, Sheyla Alfaro-Ita, José A Velasquez-Barbachan, Daniel Fernandez-Guzman, Alvaro Taype-Rondan, Joan Caballero-Luna, Fabiola Huaroto-Ramírez
{"title":"【秘鲁社会保障局（EsSalud）肝细胞癌患者管理临床实践指南】。","authors":"Javier Díaz-Ferrer, Carolina J Delgado-Flores, Edgar Fermin Yan-Quiroz, Carol Gonzales-Gonzales, Carlos Arroyo-Basto, Tayana Bedregal-Mendoza, Cecilia Yerén-Paredes, Sheyla Alfaro-Ita, José A Velasquez-Barbachan, Daniel Fernandez-Guzman, Alvaro Taype-Rondan, Joan Caballero-Luna, Fabiola Huaroto-Ramírez","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This article summarizes the clinical practice guide (CPG) for management of patients with hepatocellular carcinoma (HCC) in the Social Security of Peru (EsSalud).</p><p><strong>Objective: </strong>To provide evidence-based clinical recommendations for management of patients with HCC in EsSalud.</p><p><strong>Materials and methods: </strong>A guideline development group (GDG) was formed, which included specialist physicians and methodologists, who formulated clinical questions. Systematic searches of systematic reviews were conducted and - when deemed relevant - primary studies in PubMed during 2024. Evidence was selected to answer each of the proposed clinical questions. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. In periodic working meetings, the GDG used the GRADE methodology to review the evidence and formulate recommendations, points of good clinical practice, and flowcharts. Finally, the CPG was approved with Resolution No. 53-IETSI-ESSALUD-2024.</p><p><strong>Results: </strong>The CPG addressed 8 clinical questions regarding management of patients with HCC. Based on these questions, 9 recommendations were formulated (8 conditional, 1 based on a Preliminary Health Technology Assessment Opinion), 12 points of good clinical practice, and 1 flow chart.</p><p><strong>Conclusion: </strong>Evidence-based recommendations were statement for the management of patients with HCC.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"84-92"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Clinical practice guideline for the management of patients with heaptocellular carcinoma in the Peruvian Social Security (EsSalud)].\",\"authors\":\"Javier Díaz-Ferrer, Carolina J Delgado-Flores, Edgar Fermin Yan-Quiroz, Carol Gonzales-Gonzales, Carlos Arroyo-Basto, Tayana Bedregal-Mendoza, Cecilia Yerén-Paredes, Sheyla Alfaro-Ita, José A Velasquez-Barbachan, Daniel Fernandez-Guzman, Alvaro Taype-Rondan, Joan Caballero-Luna, Fabiola Huaroto-Ramírez\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>This article summarizes the clinical practice guide (CPG) for management of patients with hepatocellular carcinoma (HCC) in the Social Security of Peru (EsSalud).</p><p><strong>Objective: </strong>To provide evidence-based clinical recommendations for management of patients with HCC in EsSalud.</p><p><strong>Materials and methods: </strong>A guideline development group (GDG) was formed, which included specialist physicians and methodologists, who formulated clinical questions. Systematic searches of systematic reviews were conducted and - when deemed relevant - primary studies in PubMed during 2024. Evidence was selected to answer each of the proposed clinical questions. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. In periodic working meetings, the GDG used the GRADE methodology to review the evidence and formulate recommendations, points of good clinical practice, and flowcharts. Finally, the CPG was approved with Resolution No. 53-IETSI-ESSALUD-2024.</p><p><strong>Results: </strong>The CPG addressed 8 clinical questions regarding management of patients with HCC. Based on these questions, 9 recommendations were formulated (8 conditional, 1 based on a Preliminary Health Technology Assessment Opinion), 12 points of good clinical practice, and 1 flow chart.</p><p><strong>Conclusion: </strong>Evidence-based recommendations were statement for the management of patients with HCC.</p>\",\"PeriodicalId\":35807,\"journal\":{\"name\":\"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru\",\"volume\":\"45 1\",\"pages\":\"84-92\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
[Clinical practice guideline for the management of patients with heaptocellular carcinoma in the Peruvian Social Security (EsSalud)].
Introduction: This article summarizes the clinical practice guide (CPG) for management of patients with hepatocellular carcinoma (HCC) in the Social Security of Peru (EsSalud).
Objective: To provide evidence-based clinical recommendations for management of patients with HCC in EsSalud.
Materials and methods: A guideline development group (GDG) was formed, which included specialist physicians and methodologists, who formulated clinical questions. Systematic searches of systematic reviews were conducted and - when deemed relevant - primary studies in PubMed during 2024. Evidence was selected to answer each of the proposed clinical questions. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. In periodic working meetings, the GDG used the GRADE methodology to review the evidence and formulate recommendations, points of good clinical practice, and flowcharts. Finally, the CPG was approved with Resolution No. 53-IETSI-ESSALUD-2024.
Results: The CPG addressed 8 clinical questions regarding management of patients with HCC. Based on these questions, 9 recommendations were formulated (8 conditional, 1 based on a Preliminary Health Technology Assessment Opinion), 12 points of good clinical practice, and 1 flow chart.
Conclusion: Evidence-based recommendations were statement for the management of patients with HCC.
期刊介绍：
La REVISTA DE GASTROENTEROLOGíA DEL PERÚ, es la publicación oficial de la Sociedad de Gastroenterología del Perú que publica artículos originales, artículos de revisión, reporte de casos, cartas e información general de la especialidad; dirigido a los profesionales de la salud con especial interés en la gastroenterología. La Revista de Gastroenterología del Perú es una publicación de periodicidad trimestral y tiene como objetivo la publicación de artículos científicos inéditos en el campo de la gastroenterología, proporcionando información actualizada y relevante de la especialidad y áreas afines. La Revista de Gastroenterología del Perú publica artículos en dos idiomas, español e inglés, a texto completo en la versión impresa yelectrónica. Los artículos científicos son sometidos a revisores o árbitros nacionales e internacionales, especialistas que opinan bajo la modalidad de doble ciego y de manera anónima sobre la calidad y validez de los mismos. El número de revisores depende del tipo de artículo, dos revisores como mínimo para artículos originales y uno como mínimo para otros tipos de artículos.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
